Well intervention or well work is the operation performed on oil and gas wells during their productive life, which alters the well geometry and manages the production of wells by providing extensive well diagnostics. Market Research Future (MRFR) has recently published a detailed report on the global well intervention market asserting that the global market for well intervention is anticipated to expand at a steady CAGR of 3.5% during the forecast period of 2017-2023.
Global Key Players and Competition Analysis
The key players of well intervention market are GE Oil & Gas (U.K.), Halliburton Company (U.S.), Schlumberger Limited (U.S.), TechnipFMC plc. (U.K.), Baker Hughes Incorporated (U.S.), Weatherford International plc. (Switzerland), Archer Limited (U.K.), Trican Well Service Ltd. (Canada), Superior Energy Services, Inc. (U.S.), Basic Energy Services, Inc. (U.S.) and Others.
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/2810
Segmentation Analysis
The global well intervention market has been segmented based on services and applications. Based on services, the well intervention market has been segmented into logging & bottom hole survey, stimulation, artificial lift, re-perforation and others.
Regional Analysis
The Asia Pacific and Africa regions are emerging as significant regions in the Global Well Intervention Market owing to the increased utilization of well intervention services in the oil and natural gas sector of these regions.
Market Scope
One of the major factors driving the growth of the market is the continuous depletion of oil reserves and the ever-increasing demand for oil all over the world. There is a rapid increase in demand for energy owing to factors such as rapid urbanization and industrialization. The growth in demand for energy is also driving the growth of the oil and gas industry.
Browse the market data and information spread across 111 pages with 26 data tables and 12 figures of the report “Global Well Intervention Market Research Report - Forecast to 2023” in-depth alongside table of content (TOC) at: https://www.marketresearchfuture.com/reports/well-intervention-market-2810
Industry News
OWI MENA 2018 has arranged a workshop in Abu Dhabi on 9th and 10th October 2018 which will be joined by ADNOC, PDO, Petropars, Dragon Oil, SNOC and other regional operators along with 150+ well intervention experts to discuss their well intervention strategies in order to increase efficiencies and reduce the cost of on-shore as well as off-shore projects.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
To stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +16468459312
Email: [email protected]
Global Crane Market is projected to display a robust growth represented by a CAGR of 2.47% during 2018-2023.
Fixed cranes segment has more market share and is expected to continue the leadership in the forecast period on the back of growing infrastructure & real estate industry globally coupled with growing shipyards & freight business in major countries of the world,.
Amongst the regions, Asia Pacific accounts for the largest regional share in the global crane market in 2018.
Key factors driving the robust Asia Pacific market is the increasing commercial and industrial activities with growing demanding for infrastructure development.
The report has covered and analyzed the potential of Global Crane Market and provides statistics and information on market size, shares and growth factors.
The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation.
Global Oil Well Cementing Market: Trending in 2021 New York, NY 28 May 2021: The global oil well cementing market was estimated at a worth of USD 503.0 million in 2017 and is projected to grow at a CAGR of 6.3% over the forecast period.
There are several grades of these cement products, but majorly are categorized into ordinary, moderate sulfate resistant (MSR), and high sulfate resistant (HSR).
On the basis of application, the global market is further segmented into onshore and offshore.
MSR usually generates less heat of hydration at a slower rate than cement Type I and thus, this cement is used in mass structures such as retaining walls, large piers, and heavy abutments.
The product is manufactured from clinkers of Portland cements and also from cements that are hydraulically blended.
Oil well cements are formulated for resisting high pressures and temperatures within the wellbore.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
